Key result
Measurement of platelet activation markers, including surface membrane changes and released compounds, provides potential indicators for assessing high prothrombotic risk.
This review summarizes the methods and parameters for measuring platelet activation and reactivity, highlighting their potential clinical value as indicators of prothrombotic risk.
Platelet activation markers may aid prothrombotic risk assessment; leaves open prospective validation before clinical adoption.
Platelets adhere to the subendothelium that is exposed at sites of vessel wall injury to form a primary haemostatic plug by aggregating together. Activated platelets support fibrin formation by exposing a procoagulant surface and encrypting circulating tissue factor. Through this process platelets are essential components of haemostasis and also of arterial thrombosis. Evidence has been provided that detection of circulating activated and/or hyperreactive platelets may indicate a high thrombotic risk. The aim of the present review is to present an overview of the various parameters that can be measured and that provide information on platelet activation and reactivity, such as changes in platelet surface membrane properties (e.g. CD62P expression, binding of PAC-1, fibrinogen or annexin V), release of stored compounds (e.g. ß-thromboglobulin, platelet factor 4 or CD62P), formation of procoagulant membranous microvesicles, measurements of platelet adhesion, platelet aggregation and platelet-leukocyte conjugate formation and changes in platelet volume. The methods that can be used to measure the various parameters are briefly described. We also refer to various pitfalls in pre-analysis and data interpretation. Throughout we direct the readers’ attention to published studies that indicate the potential value of the various measured parameters as indicators of thrombotic risk.
No takes yet. Share an insight, caveat, or question.
Lösche et al. (2007) conducted a review in Thrombotic risk. Platelet activation markers was evaluated. Measurement of platelet activation markers, including surface membrane changes and released compounds, provides potential indicators for assessing high prothrombotic risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: